SONN icon

Sonnet BioTherapeutics
SONN

Overview Fund Activity

8 hedge funds and large institutions have $2.78M invested in Sonnet BioTherapeutics in 2013 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, reducing their positions, and 0 closing their positions.

Holders
8
Holders Change
+4
Holders Change %
+100%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
TDC
1
Thompson Davis & Co
Virginia
$735K
2
Hudson Bay Capital Management
2
Hudson Bay Capital Management
Connecticut
$177K
3
BIT
3
BlackRock Institutional Trust
California
$304K
4
U
4
UBS
Switzerland
$11K
5
Citigroup
5
Citigroup
New York
$4K

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
Millennium Management
1
Millennium Management
New York
$1.19M 222,222 – –
TDC
2
Thompson Davis & Co
Virginia
$735K 136,786 +136,786 New
BIT
3
BlackRock Institutional Trust
California
$304K 56,692 +10,398 +22%
CDH
4
Charles D. Hyman
$239K 44,444 – –
Hudson Bay Capital Management
5
Hudson Bay Capital Management
Connecticut
$177K 40,000 +40,000 New
Bank of America
6
Bank of America
North Carolina
$115K 21,438 +10 +0%
U
7
UBS
Switzerland
$11K 2,000 +2,000 New
Citigroup
8
Citigroup
New York
$4K 750 +750 New